Posted on 1/3/18
Celgene - Don't Forget The Pipeline
A tale of two halves - 20172017 has been an interesting year for Celgene as a whole. What began in 2017 as a strong bull-run for . . .
A tale of two halves - 20172017 has been an interesting year for Celgene as a whole. What began in 2017 as a strong bull-run for . . .